Skip to main content

Table 1 Participants’ characteristics

From: The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes

Characteristics

Control group

n = 150

Intervention group

n = 152

n (%)

n (%)

General characteristics

 Sex, female

98 (65.3)

109 (71.7)

 Age, mean (SD)

60.0 (9.2)

59.0 (9.5)

 Educational level

  Elementary school or less

21 (14.0)

19 (12.5)

  Secondary school

36 (24.0)

43 (28.3)

  High school

62 (41.3)

60 (39.5)

  University degree

31 (20.7)

30 (19.7)

Clinical characteristics

 Body mass index (kg/m2), mean (SD)

30.3 (5.7)

29.4 (4.7)

 Nutritional status

  Normal weight (BMI: 18.5–24.9 kg/m2)

21 (14.0)

28 (18.4)

  Overweight (BMI: 25.0–29.9 kg/m2)

63 (42.0)

61 (40.1)

  Obesity (BMI ≥ 30 kg/m2)

66 (44.0)

63 (41.5)

  Time since diabetes diagnosis (years), mean (SD)

14.3 (9.3)

14.0 (8.1)

Baseline pharmacologic treatment

 Insulin****

73 (48.7)

110 (72.4)

 Metformin

115 (76.7)

123 (80.9)

 Glibenclamide**

53 (35.3)

32 (21.1)

 Pioglitazone

6 (4.0)

10 (6.6)

 Linagliptin

46 (30.7)

56 (36.8)

 Baseline HbA1c (%), mean (SD)***

9.3 (1.0)

9.8 (1.4)

 Modifications to treatment following the baseline evaluation*

99 (66.0)

74 (48.7)

 Loss of follow-up

12 (8.0)

22 (14.5)

 Missing CGM information at three-month evaluation

 

14 (9.2%)

  1. SD Standard deviation
  2. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001